US Stock MarketDetailed Quotes

XBIO Xenetic Biosciences

Watchlist

4.2900
+0.0100+0.23%

Close Dec 20 16:00 ET

6.62MMarket Cap-1.61P/E (TTM)

Xenetic Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

51.66%-459.04K

58.62%-525.1K

-5.16%-1.16M

11.46%-4.11M

-5.61%-793.03K

12.01%-949.63K

-74.11%-1.27M

47.19%-1.1M

1.93%-4.65M

48.52%-750.91K

Net income from continuing operations

58.63%-436.67K

-21.22%-1.27M

-39.53%-1.2M

36.90%-4.13M

20.98%-1.17M

-31.29%-1.06M

60.67%-1.05M

46.25%-856.55K

-16.07%-6.55M

19.50%-1.48M

Depreciation and amortization

----

--0

----

-23.78%27.04K

--0

Other non cash items

----

--1.79M

--488.75K

Change In working capital

-239.96%-49.9K

345.79%706.77K

86.88%-41.31K

38.43%-262.73K

144.63%303.9K

108.48%35.66K

-158.35%-287.55K

49.49%-314.74K

-192.52%-426.69K

-52.33%124.23K

-Change in prepaid assets

427.06%528.29K

62.86%-164.34K

116.16%51.79K

53.99%-47.73K

469.94%876.73K

-232.75%-161.53K

-261.48%-442.5K

-22.10%-320.45K

-136.27%-103.74K

-168.00%-236.99K

-Change in payables and accrued expense

-393.23%-578.2K

5,726.81%871.11K

57.06%-93.09K

24.25%-263.57K

-1,261.14%-258.91K

186.36%197.18K

-93.08%14.95K

39.42%-216.79K

-176.12%-347.95K

-92.56%22.3K

-Change in other current assets

--0

94.32%48.58K

-192.62%-313.92K

--0

4,776.35%140K

7,849.91%222.5K

108.87%25K

187.46%338.92K

Cash from discontinued investing activities

Operating cash flow

51.66%-459.04K

58.62%-525.1K

-5.16%-1.16M

11.46%-4.11M

-5.61%-793.03K

12.01%-949.63K

-74.11%-1.27M

47.19%-1.1M

1.93%-4.65M

48.52%-750.91K

Investing cash flow

Cash flow from continuing investing activities

-500K

Net intangibles purchase and sale

----

--0

----

---500K

--0

Cash from discontinued investing activities

Investing cash flow

----

--0

----

---500K

--0

Financing cash flow

Cash flow from continuing financing activities

Cash from discontinued financing activities

Net cash flow

Beginning cash position

-31.95%7.3M

-34.77%7.82M

-31.41%8.98M

-28.21%13.1M

-29.41%9.78M

-28.15%10.73M

-25.76%11.99M

-28.21%13.1M

58.26%18.24M

-29.71%13.85M

Current changes in cash

51.66%-459.04K

58.62%-525.1K

-5.16%-1.16M

20.06%-4.11M

-5.61%-793.03K

12.01%-949.63K

-3.27%-1.27M

47.19%-1.1M

-176.63%-5.15M

48.52%-750.91K

End cash Position

-30.04%6.84M

-31.95%7.3M

-34.77%7.82M

-31.41%8.98M

-29.41%9.78M

-28.15%10.73M

-25.76%11.99M

-28.21%13.1M

Free cash flow

51.66%-459.04K

58.62%-525.1K

-5.16%-1.16M

20.06%-4.11M

-5.61%-793.03K

12.01%-949.63K

-3.27%-1.27M

47.19%-1.1M

-8.63%-5.15M

48.52%-750.91K

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	51.66%-459.04K	58.62%-525.1K	-5.16%-1.16M	11.46%-4.11M	-5.61%-793.03K	12.01%-949.63K	-74.11%-1.27M	47.19%-1.1M	1.93%-4.65M	48.52%-750.91K
Net income from continuing operations	58.63%-436.67K	-21.22%-1.27M	-39.53%-1.2M	36.90%-4.13M	20.98%-1.17M	-31.29%-1.06M	60.67%-1.05M	46.25%-856.55K	-16.07%-6.55M	19.50%-1.48M
Depreciation and amortization	----	----	----	--0	----	----	----	----	-23.78%27.04K	--0
Other non cash items	----	----	----	----	----	----	----	----	--1.79M	--488.75K
Change In working capital	-239.96%-49.9K	345.79%706.77K	86.88%-41.31K	38.43%-262.73K	144.63%303.9K	108.48%35.66K	-158.35%-287.55K	49.49%-314.74K	-192.52%-426.69K	-52.33%124.23K
-Change in prepaid assets	427.06%528.29K	62.86%-164.34K	116.16%51.79K	53.99%-47.73K	469.94%876.73K	-232.75%-161.53K	-261.48%-442.5K	-22.10%-320.45K	-136.27%-103.74K	-168.00%-236.99K
-Change in payables and accrued expense	-393.23%-578.2K	5,726.81%871.11K	57.06%-93.09K	24.25%-263.57K	-1,261.14%-258.91K	186.36%197.18K	-93.08%14.95K	39.42%-216.79K	-176.12%-347.95K	-92.56%22.3K
-Change in other current assets	--0	--0	--0	94.32%48.58K	-192.62%-313.92K	--0	4,776.35%140K	7,849.91%222.5K	108.87%25K	187.46%338.92K
Cash from discontinued investing activities
Operating cash flow	51.66%-459.04K	58.62%-525.1K	-5.16%-1.16M	11.46%-4.11M	-5.61%-793.03K	12.01%-949.63K	-74.11%-1.27M	47.19%-1.1M	1.93%-4.65M	48.52%-750.91K
Investing cash flow
Cash flow from continuing investing activities				0					-500K	0
Net intangibles purchase and sale	----	----	----	--0	----	----	----	----	---500K	--0
Cash from discontinued investing activities
Investing cash flow	----	----	----	--0	----	----	----	----	---500K	--0
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position	-31.95%7.3M	-34.77%7.82M	-31.41%8.98M	-28.21%13.1M	-29.41%9.78M	-28.15%10.73M	-25.76%11.99M	-28.21%13.1M	58.26%18.24M	-29.71%13.85M
Current changes in cash	51.66%-459.04K	58.62%-525.1K	-5.16%-1.16M	20.06%-4.11M	-5.61%-793.03K	12.01%-949.63K	-3.27%-1.27M	47.19%-1.1M	-176.63%-5.15M	48.52%-750.91K
End cash Position	-30.04%6.84M	-31.95%7.3M	-34.77%7.82M	-31.41%8.98M	-31.41%8.98M	-29.41%9.78M	-28.15%10.73M	-25.76%11.99M	-28.21%13.1M	-28.21%13.1M
Free cash flow	51.66%-459.04K	58.62%-525.1K	-5.16%-1.16M	20.06%-4.11M	-5.61%-793.03K	12.01%-949.63K	-3.27%-1.27M	47.19%-1.1M	-8.63%-5.15M	48.52%-750.91K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data